Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays.

Authors:
Tan SS; Saw S; Chew KL; Huak CY; Khoo C and 6 more

Journal:
Pathology

Publication Year: 2020

DOI:
10.1016/j.pathol.2020.09.007

PMCID:
PMC7524664

PMID:
33092816

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pathology

Abbreviation: Pathology

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pathology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SAR…
Phan T; Tran NYK; Gottlieb T and 2 more (2022) - Transparency Score: 2/6
SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic n…
Fox-Lewis A; Fox-Lewis S; Beaumont J and 13 more (2021) - Transparency Score: 1/6
Use of emerging testing technologies and approaches for SARS-CoV-2: review of literature and global…
Graham M; Ballard SA; Pasricha S and 8 more (2021) - Transparency Score: 2/6
Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biologi…
Kaufer AM; Theis T; Lau KA and 2 more (2020) - Transparency Score: 1/6
Laboratory diagnosis of severe acute respiratory syndrome coronavirus 2.
Gulholm T; Basile K; Kok J and 2 more (2020) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest and sources of funding PT has received grants paid to the 10.13039/100004337National University Hospital from Roche (CP40617, MV40618), Johnson & Johnson (63623872FLZ3001, 63623872FLZ2002), 10.13039/100014588Sanofi Pasteur (H-030-014), 10.13039/100004330GlaxoSmithKline, and 10.13039/501100005612Shionogi (1601T0831). All other authors have no conflicts of interest to declare. No external funding was received for this study."

Evidence found in paper:

"10.13039/100004337National University Hospital from Roche; Johnson & Johnson; 10.13039/100014588Sanofi Pasteur; 10.13039/100004330GlaxoSmithKline; 10.13039/501100005612Shionogi"

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025